Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05028751
Title A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kronos Bio
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
University of California Los Angeles (UCLA) Los Angeles California 990095 United States Details
The Blood and Marrow Transplant Group of Georgia Atlanta Georgia 30342 United States Details
University of Chicago Medical Center Chicago Illinois 60637 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
Hospital Universitario 12 de Octubre Madrid Avenida De Córdoba Sin Número 28041 Spain Details
Hospital Germans Trias i Pujol Barcelona Badalona 08916 Spain Details
MD Anderson Cancer Center Madrid Madrid Calle De Arturo Soria 270 Spain Details
Hospital Universitari Vall d'Hebrón Barcelona 08035 Spain Details
Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet) Barcelona 08908 Spain Details
Hospital Clínic de Barcelona Barcelona 170 Spain Details
Hospital San Pedro de Alcantara Cáceres 10001 Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid 28040 Spain Details
Hospital Universitari i Politècnic La Fe Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field